Tevogen board shrinks to five after director Susan Podlogar resigns
Podlogar stepped down effective November 2, 2026, and the board named Lindee Goh to the Audit Committee the same day.
Tevogen Inc. disclosed in an 8-K filing that director Susan Podlogar resigned from its board, effective immediately, on November 2, 2026. On November 2, 2026, Susan Podlogar gave notice of her resignation from service as a director of Tevogen Inc., effective immediately.1
Following the resignation, Tevogen's board took two actions, both effective the same day. The board cut the number of directors from six to five and named current director Lindee Goh to the Audit Committee, both effective November 2, 2026.1
The filing was signed on November 4, 2026 by Chief Executive Officer Ryan Saadi. Date: November 4, 2026, By: /s/ Ryan Saadi, Name: Ryan Saadi, Title: Chief Executive Officer.1
Tevogen Inc. trades on Nasdaq under the ticker TVGN, with its warrants listed as TVGNW. Common Stock, par value $0.0001 per share, trades under TVGN, and warrants exercisable for one share of common stock at $11.50 per share trade under TVGNW, both on The Nasdaq Stock Market LLC.1
The filing did not disclose a reason for Podlogar's departure or name a replacement director.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.